International Network of VENous Thromboembolism Clinical Research Networks


Site News
« Back to listings

Melbourne, Australia  - At the Annual General Meeting (Council) on July 9th, 2019 at ISTH 2019 Congress in Melbourne, Australia, INVENT Council endorsed four clinical VTE studies / trials. The following studies were endorsed by the Network:

  • The REDUCE Study: Management of recurrent venous thromboembolism during anticoagulant treatment in cancer patients - a prospective cohort study.
  • ADJUST-DVT: Age-adjusted D-dimer cut-off levels to rule out deep vein thrombosis - a prospective outcome study. 
  • Pilot PARTUM Trial- a pilot study assessing the feasibility of a randomized controlled trial evaluating aspirin in postpartum women at risk of developing venous thromboembolism.
  • The RHEA Study: Optimizing diagnosis of splanchnic vein thrombosis with MR direct thrombus imaging

The INVENT Network has now endorsed 14 studies since its inception in 2016. For the complete list, please visit our website here.



There are currently no comments.

Log in to post a comment.


* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.